國立虎尾科技大學 |

Fluoroquinolone-Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic Criteria = Side-effects of Fluoroquinolones /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Fluoroquinolone-Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic Criteria / by Stefan Pieper.
Reminder of title:	Side-effects of Fluoroquinolones /
Author:	Pieper, Stefan.
Description:	X, 70 p. 2 illus.online resource. :
Contained By:	Springer Nature eBook
Subject:	Internal medicine. -
Online resource:	https://doi.org/10.1007/978-3-030-74173-0
ISBN:	9783030741730

Fluoroquinolone-Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic Criteria = Side-effects of Fluoroquinolones /
Pieper, Stefan.

Fluoroquinolone-Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic Criteria Side-effects of Fluoroquinolones /[electronic resource] :by Stefan Pieper. - 1st ed. 2021. - X, 70 p. 2 illus.online resource.

1 Introduction to Fluoroquinolone-Associated Disability (FQAD) -- 2 FQAD and Oxidative Stress and Mitochondrial Toxicity -- 3 FQAD and Musculoskeletal Damage / Collagen Disorder -- 4 FQAD and Neurotoxicity / Peripheral Neuropathy (PN) / Autonomic Neuropathy / Small Fibre Neuropathy -- 5 FQAD and Neuropsychiatric Adverse Effects -- 6 Diagnostic criteria of the FQAD -- 7 Inside Story - Practical experience with FQAD Patients.

In this book, Stefan Pieper supports doctors and therapists in easily diagnosing FQAD and in better and more adequately dealing with FQAD patients. Fluoroquinolones, as one of the most common and effective groups of antibiotics, are known to have a distinct spectrum of side effects. These adverse effects are rare in percentage terms, but frequent in absolute numbers due to the enormous quantities of prescriptions. Because they are usually quite severe and wide-ranging, they tend to run like a syndrome and have been classified by the FDA as a separate condition, the FQAD, because of their frequency, severity and risk of disability. This book presents for the first time a comprehensive description and classification of the clinical picture and a proposal for a clinical diagnostic tool based on diagnostic criteria.

ISBN: 9783030741730

Standard No.: 10.1007/978-3-030-74173-0doiSubjects--Topical Terms:

644638
Internal medicine.

LC Class. No.: RC1-1245

Dewey Class. No.: 616

Fluoroquinolone-Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic Criteria = Side-effects of Fluoroquinolones /
LDR:02584nam a22003855i 4500 001 1055309
003 DE-He213
005 20210823195808.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030741730 $9 978-3-030-74173-0
024 7 $a 10.1007/978-3-030-74173-0 $2 doi
035 $a 978-3-030-74173-0
050 4 $a RC1-1245
072 7 $a MJ $2 bicssc
072 7 $a MED045000 $2 bisacsh
072 7 $a MJ $2 thema
082 0 4 $a 616 $2 23
100 1 $a Pieper, Stefan. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1318225
245 1 0 $a Fluoroquinolone-Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic Criteria $h [electronic resource] : $b Side-effects of Fluoroquinolones / $c by Stefan Pieper.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a X, 70 p. 2 illus. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a 1 Introduction to Fluoroquinolone-Associated Disability (FQAD) -- 2 FQAD and Oxidative Stress and Mitochondrial Toxicity -- 3 FQAD and Musculoskeletal Damage / Collagen Disorder -- 4 FQAD and Neurotoxicity / Peripheral Neuropathy (PN) / Autonomic Neuropathy / Small Fibre Neuropathy -- 5 FQAD and Neuropsychiatric Adverse Effects -- 6 Diagnostic criteria of the FQAD -- 7 Inside Story - Practical experience with FQAD Patients.
520 $a In this book, Stefan Pieper supports doctors and therapists in easily diagnosing FQAD and in better and more adequately dealing with FQAD patients. Fluoroquinolones, as one of the most common and effective groups of antibiotics, are known to have a distinct spectrum of side effects. These adverse effects are rare in percentage terms, but frequent in absolute numbers due to the enormous quantities of prescriptions. Because they are usually quite severe and wide-ranging, they tend to run like a syndrome and have been classified by the FDA as a separate condition, the FQAD, because of their frequency, severity and risk of disability. This book presents for the first time a comprehensive description and classification of the clinical picture and a proposal for a clinical diagnostic tool based on diagnostic criteria.
650 0 $a Internal medicine. $3 644638
650 0 $a General practice (Medicine). $3 1253458
650 0 $a Critical care medicine. $3 644413
650 1 4 $a Internal Medicine. $3 668583
650 2 4 $a General Practice / Family Medicine. $3 593966
650 2 4 $a Intensive / Critical Care Medicine. $3 673790
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030741723
776 0 8 $i Printed edition: $z 9783030741747
856 4 0 $u https://doi.org/10.1007/978-3-030-74173-0
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)